Cross-presentation of dead-cell-associated antigens by DNGR-1+ dendritic cells contributes to chronic allograft rejection in mice
- PMID: 32640051
- DOI: 10.1002/eji.201948501
Cross-presentation of dead-cell-associated antigens by DNGR-1+ dendritic cells contributes to chronic allograft rejection in mice
Abstract
The purpose of this study was to elucidate whether DC NK lectin group receptor-1 (DNGR-1)-dependent cross-presentation of dead-cell-associated antigens occurs after transplantation and contributes to CD8+ T cell responses, chronic allograft rejection (CAR), and fibrosis. BALB/c or C57BL/6 hearts were heterotopically transplanted into WT, Clec9a-/- , or Batf3-/- recipient C57BL/6 mice. Allografts were analyzed for cell infiltration, CD8+ T cell activation, fibrogenesis, and CAR using immunohistochemistry, Western blot, qRT2 -PCR, and flow cytometry. Allografts displayed infiltration by recipient DNGR-1+ DCs, signs of CAR, and fibrosis. Allografts in Clec9a-/- recipients showed reduced CAR (p < 0.0001), fibrosis (P = 0.0137), CD8+ cell infiltration (P < 0.0001), and effector cytokine levels compared to WT recipients. Batf3-deficiency greatly reduced DNGR-1+ DC-infiltration, CAR (P < 0.0001), and fibrosis (P = 0.0382). CD8 cells infiltrating allografts of cytochrome C treated recipients, showed reduced production of CD8 effector cytokines (P < 0.05). Further, alloreactive CD8+ T cell response in indirect pathway IFN-γ ELISPOT was reduced in Clec9a-/- recipient mice (P = 0.0283). Blockade of DNGR-1 by antibody, similar to genetic elimination of the receptor, reduced CAR (P = 0.0003), fibrosis (P = 0.0273), infiltration of CD8+ cells (p = 0.0006), and effector cytokine levels. DNGR-1-dependent alloantigen cross-presentation by DNGR-1+ DCs induces alloreactive CD8+ cells that induce CAR and fibrosis. Antibody against DNGR-1 can block this process and prevent CAR and fibrosis.
Keywords: CD8+ T cells; DNGR-1; cDC1; cross-presentation; transplantation.
© 2020 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
References
-
- Racusen, L. C., Solez, K. and Colvin, R., Fibrosis and atrophy in the renal allograft: interim report and new directions. Am. J. Transplant. 2002. 2: 203-206.
-
- Brunner, S. M., Schiechl, G., Kesselring, R., Martin, M., Balam, S., Schlitt, H. J., Geissler, E. K. et al., IL-13 signaling via IL-13Ralpha2 triggers TGF-beta1-dependent allograft fibrosis. Transplant. Res. 2013. 2: 16.
-
- Pichler, M., Rainer, P. P., Schauer, S. and Hoefler G., Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J. Am. Coll. Cardiol. 2012. 59: 1008-1016.
-
- Huibers, M., De Jonge, N., Van Kuik, J., Siera-De Koning, E., Van Wichen, D., Dullens, H., Schipper, M. et al., Intimal fibrosis in human cardiac allograft vasculopathy. Transpl. Immunol. 2011. 25: 124-132.
-
- Brunner, S. M., Schiechl, G., Falk, W., Schlitt, H. J., Geissler, E. K. and Fichtner-Feigl, S., Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl. Int. 2011. 24: 1027-1039.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
